Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial (RCT) of StriveWeekly for Anxiety and Depression Prevention for College Students During COVID-19 (Coronavirus Disease 2019)

NCT04927845 is registered in ClinicalTrials.gov with Harvard University as lead sponsor.

NCT NCT04927845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04927845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial (RCT) of StriveWeekly for Anxiety and Depression Prevention for College Students During COVID-19 (Coronavirus Disease 2019)
Lead sponsor
Harvard University
Phase
Not applicable
Overall status
Completed
Start date
May 19, 2021
Completion date
June 10, 2022
Enrollment
538 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety, depressive symptoms, stress, emotional